Erythrocyte-incorporated 6-Mercaptopurine Metabolite Levels Are Not Affected by Recent Drug Administration During Maintenance Therapy for Childhood Acute Lymphoblastic Leukemia
EJC Paediatric Oncology(2023)
摘要
•Maintenance therapy in childhood ALL prevents leukemic relapse.•Poor adherence to maintenance therapy explains 40–50% of ALL relapses.•Ery-TGN and ery-MeMP metabolites can be used for adherence monitoring.•Ery-MeMP and ery-TGN levels are not influenced by an individual 6-MP dose.•Blood for metabolites analysis can be drawn irrespective of timing of 6-MP intake.
更多查看译文
关键词
Leukemia,Acute,Lymphoblastic,Maintenance therapy,6-mercaptopurine,Relapse,Adherence to therapy,Drug metabolism,Pharmacokinetics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要